Literature DB >> 16651626

Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy.

Tara L Spires1, Jennifer D Orne, Karen SantaCruz, Rose Pitstick, George A Carlson, Karen H Ashe, Bradley T Hyman.   

Abstract

Neurofibrillary tangles form in a specific spatial and temporal pattern in Alzheimer's disease. Although tangle formation correlates with dementia and neuronal loss, it remains unknown whether neurofibrillary pathology causes cell death. Recently, a mouse model of tauopathy was developed that reversibly expresses human tau with the dementia-associated P301L mutation. This model (rTg4510) exhibits progressive behavioral deficits that are ameliorated with transgene suppression. Using quantitative analysis of PHF1 immunostaining and neuronal counts, we estimated neuron number and accumulation of neurofibrillary pathology in five brain regions. Accumulation of PHF1-positive tau in neurons appeared between 2.5 and 7 months of age in a region-specific manner and increased with age. Neuron loss was dramatic and region-specific in these mice, reaching over 80% loss in hippocampal area CA1 and dentate gyrus by 8.5 months. We observed regional dissociation of neuronal loss and accumulation of neurofibrillary pathology, because there was loss of neurons before neurofibrillary lesions appeared in the dentate gyrus and, conversely, neurofibrillary pathology appeared without major cell loss in the striatum. Finally, suppressing the transgene prevented further neuronal loss without removing or preventing additional accumulation of neurofibrillary pathology. Together, these results imply that neurofibrillary tangles do not necessarily lead to neuronal death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651626      PMCID: PMC1606598          DOI: 10.2353/ajpath.2006.050840

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.

Authors:  T Ishihara; M Hong; B Zhang; Y Nakagawa; M K Lee; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

2.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices.

Authors:  D A Lewis; M J Campbell; R D Terry; J H Morrison
Journal:  J Neurosci       Date:  1987-06       Impact factor: 6.167

3.  Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

Authors:  K S Kosik; C L Joachim; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

Authors:  R C Pearson; M M Esiri; R W Hiorns; G K Wilcock; T P Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study.

Authors:  J P Brion; A M Couck; E Passareiro; J Flament-Durand
Journal:  J Submicrosc Cytol       Date:  1985-01

7.  Some morphometric aspects of the brain in senile dementia of the Alzheimer type.

Authors:  R D Terry; A Peck; R DeTeresa; R Schechter; D S Horoupian
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

8.  Neurofibrillary degeneration and neuronal loss in Alzheimer's disease.

Authors:  W Bondareff; C Q Mountjoy; M Roth; D L Hauser
Journal:  Neurobiol Aging       Date:  1989 Nov-Dec       Impact factor: 4.673

9.  Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study.

Authors:  M J Ball
Journal:  Acta Neuropathol       Date:  1977-02-28       Impact factor: 17.088

10.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Authors:  B T Hyman; G W Van Hoesen; A R Damasio; C L Barnes
Journal:  Science       Date:  1984-09-14       Impact factor: 47.728

View more
  172 in total

1.  Aggregation of detergent-insoluble tau is involved in neuronal loss but not in synaptic loss.

Authors:  Tetsuya Kimura; Tetsuya Fukuda; Naruhiko Sahara; Shunji Yamashita; Miyuki Murayama; Tatsuya Mizoroki; Yuji Yoshiike; Boyoung Lee; Ioannis Sotiropoulos; Sumihiro Maeda; Akihiko Takashima
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

Review 2.  Are tangles as toxic as they look?

Authors:  Tara L Spires-Jones; Katherine J Kopeikina; Robert M Koffie; Alix de Calignon; Bradley T Hyman
Journal:  J Mol Neurosci       Date:  2011-06-03       Impact factor: 3.444

3.  Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.

Authors:  Donna M Barten; Patrizia Fanara; Cathy Andorfer; Nina Hoque; P Y Anne Wong; Kristofor H Husted; Gregory W Cadelina; Lynn B Decarr; Ling Yang; Victoria Liu; Chancy Fessler; Joan Protassio; Timothy Riff; Holly Turner; Christopher G Janus; Sethu Sankaranarayanan; Craig Polson; Jere E Meredith; Gemma Gray; Amanda Hanna; Richard E Olson; Soong-Hoon Kim; Gregory D Vite; Francis Y Lee; Charles F Albright
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

4.  Amyloid precursor protein and tau transgenic models of Alzheimer's disease: insights from the past and directions for the future.

Authors:  Naruhiko Sahara; Jada Lewis
Journal:  Future Neurol       Date:  2010-05-01

5.  Focal expression of mutated tau in entorhinal cortex neurons of rats impairs spatial working memory.

Authors:  Julio J Ramirez; Winona E Poulton; Erik Knelson; Cole Barton; Michael A King; Ronald L Klein
Journal:  Behav Brain Res       Date:  2010-08-19       Impact factor: 3.332

6.  Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.

Authors:  Laura J Blair; Bryce A Nordhues; Shannon E Hill; K Matthew Scaglione; John C O'Leary; Sarah N Fontaine; Leonid Breydo; Bo Zhang; Pengfei Li; Li Wang; Carl Cotman; Henry L Paulson; Martin Muschol; Vladimir N Uversky; Torsten Klengel; Elisabeth B Binder; Rakez Kayed; Todd E Golde; Nicole Berchtold; Chad A Dickey
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

7.  Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo.

Authors:  Sarah L DeVos; Bianca T Corjuc; Caitlin Commins; Simon Dujardin; Riley N Bannon; Diana Corjuc; Benjamin D Moore; Rachel E Bennett; Mehdi Jorfi; Jose A Gonzales; Patrick M Dooley; Allyson D Roe; Rose Pitstick; Daniel Irimia; Matthew P Frosch; George A Carlson; Bradley T Hyman
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

8.  Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy.

Authors:  Chad Dickey; Clara Kraft; Umesh Jinwal; John Koren; Amelia Johnson; Laura Anderson; Lori Lebson; Daniel Lee; Dennis Dickson; Rohan de Silva; Lester I Binder; David Morgan; Jada Lewis
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

9.  Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.

Authors:  Jennifer B Paulson; Martin Ramsden; Colleen Forster; Mathew A Sherman; Eileen McGowan; Karen H Ashe
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

10.  Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.

Authors:  Tara L Spires-Jones; Taylor Friedman; Rose Pitstick; Manuela Polydoro; Allyson Roe; George A Carlson; Bradley T Hyman
Journal:  Neurosci Lett       Date:  2014-01-21       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.